glp 1 drugs and addiction Not just obesity: GLP-1 receptor agonists advance on Caron Pioneers Novel Use of

It activates GLP-1 receptors, leading to increased insulin release from pancreatic beta cells in response to elevated blood sugar levels, making it an excellent treatment for type 2 diabetes

This program was established to test how a category of drugs for weight management becoming available under Medicare might impact beneficiaries and the Medicare program

[DOI] [PubMed] [Google Scholar] 872.Mabilleau G., Mieczkowska A., Chappard D

[Preprint] (2025)

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes

After 56 weeks, the study participants in the liraglutide group achieved an 8.4% weight loss compared to 2.8% in the placebo group (95% CI: 6.0 to 5.1